# Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial

> **NCT06818331** · PHASE2 · RECRUITING · sponsor: **The Third Affiliated hospital of Zhejiang Chinese Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Glioma

## Interventions

- **OTHER:** SMES+PTX
- **DRUG:** Paclitaxel
- **DEVICE:** Specific mode electroacupuncture stimulation

## Key facts

- **NCT ID:** NCT06818331
- **Lead sponsor:** The Third Affiliated hospital of Zhejiang Chinese Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2028-02-24
- **Final completion:** 2028-02-24
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06818331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06818331, "Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06818331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*